Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective

Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective

<b>Background:</b> In Type 1 diabetes (T1D), according to the most recent guidelines, the everyday glucose-lowering treatment is still restricted to the use of subcutaneous insulin, while multiple therapeutic options exist for Type 2 diabetes (T2D). <b>Methods:</b> For this n...

Full description

Bibliographic Details
Main Authors: Felix Aberer, Thomas R. Pieber, Max L. Eckstein, Harald Sourij, Othmar Moser
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pharmaceutics
Subjects:
Type 1 diabetes
pharmacologic treatment
randomized controlled trials
Online Access:https://www.mdpi.com/1999-4923/14/6/1180

Internet

https://www.mdpi.com/1999-4923/14/6/1180

Similar Items